Related Experiment Video
Updated: May 10, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Paroxysmal sympathetic hyperactivity after acute brain injury.
H Alex Choi1, Sang-Beom Jeon, Sophie Samuel
1Departments of Neurology and Neurosurgery, The University of Texas Medical School at Houston, 6431 Fannin St., MSB 7.154A, Houston, TX 77030, USA. huimahn.a.choi@uth.tmc.edu
Paroxysmal sympathetic hyperactivity (PSH) is a serious syndrome following brain injury. Effective management requires a balanced approach to control episodes without causing oversedation.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Neurology
Background:
- Paroxysmal sympathetic hyperactivity (PSH) is a syndrome linked to brain injuries like trauma, stroke, and encephalitis.
- It presents with episodes of sympathetic surges, leading to hyperthermia, diaphoresis, tachycardia, hypertension, tachypnea, and dystonic posturing.
- Patients with PSH experience poorer neurological outcomes, extended hospital stays, and increased complications.
Purpose of the Study:
- To highlight the lack of consensus on diagnostic criteria, risk factors, pathophysiology, and treatment for PSH.
- To emphasize the recent focus on establishing diagnostic criteria and proposing new pathophysiological theories.
- To review available treatment options and the limited systemic studies on treatment algorithm efficacy.
Main Methods:
- Review of existing literature on paroxysmal sympathetic hyperactivity.
- Analysis of proposed diagnostic criteria and pathophysiological theories.
- Evaluation of current treatment strategies and their efficacy.
Main Results:
- Consensus on diagnostic criteria, risk factors, and pathophysiology for PSH remains limited.
- New theories regarding PSH pathophysiology have been recently proposed.
- Various medications can be used in combination for regular management, with as-needed medications for acute episodes.
Conclusions:
- Effective PSH management requires a balanced approach, combining scheduled and as-needed medications.
- The goal is to control symptoms and reduce episode frequency/intensity without causing oversedation.
- Further systemic studies are needed to validate treatment algorithms for PSH.
Related Concept Videos
Sympathetic Activation
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Secondary Spinal Cord Injury llI: Pathophysiology
Traumatic Brain Injury l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Autonomic Nervous System
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...

